Global Characterization of Protein Palmitoylation in Trypanosomes

锥虫中蛋白质棕榈酰化的整体表征

基本信息

  • 批准号:
    8829304
  • 负责人:
  • 金额:
    $ 36.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Global Characterization of Protein Palmitoylation in Trypanosomes Palmitoylation is a posttranslational modification of proteins that can affect how a protein interacts with lipids and proteins in a membrane compartment. Dual aminoacylation with myristate and palmitate is essential for targeting of proteins to lipid rafts, and is a common feature of key molecules in cell signaling. While N- myristoylation is carried out in the endoplasmic reticulum by a single N-myristoyltransferase, S-palmitoylation, and rarely N-palmitoylation (occurring on an N-terminal cys residue), is mediated by one of a number of palmitoyl acyltransferases (PATs), each having its own localization and substrate specificity. S-palmitoylation is essential for the functions of a number of important proteins and is essential in eukaryotes. Thus, the identification and linkage of specific PATs and their substrates constitutes a unique approach to systematic analysis eukaryote biology. In the African trypanosome, Trypanosoma brucei, our LC-MS/MS and RNAi data strongly suggest that protein palmitoylation is an abundant and important modification. In the proposed project, we will conduct a global analysis of protein palmitoylation in T. brucei in a five-year intensive research effort that will determine the palmitoylproteomes of T. brucei, identify the substrate profiles and functions of T. brucei PATs, and investigate this class of enzymes as potential targets for trypanocidal chemotherapy.
描述(由申请方提供):锥虫中蛋白质棕榈酰化的总体表征棕榈酰化是一种蛋白质的翻译后修饰,可影响蛋白质如何与膜隔室中的脂质和蛋白质相互作用。肉豆蔻酸酯和棕榈酸酯的双重氨酰化对于蛋白质靶向脂筏是必需的,并且是常见的 细胞信号传导中关键分子的特征。虽然N-肉豆蔻酰化在内质网中通过单个N-肉豆蔻酰转移酶进行,但S-棕榈酰化和很少的N-棕榈酰化(发生在N-末端半胱氨酸残基上)由许多棕榈酰酰基转移酶(PAT)中的一种介导,每种具有其自身的定位和底物特异性。S-棕榈酰化对于许多重要蛋白质的功能是必不可少的, 真核生物因此,鉴定和连接特定的PAT及其底物构成了系统分析真核生物生物学的独特方法。在非洲锥虫,布氏锥虫,我们的LC-MS/MS和RNAi数据强烈表明,蛋白质棕榈酰化是一个丰富的和重要的修改。在这个项目中,我们将对T. brucei在一个为期五年的密集的研究工作,将确定棕榈酰蛋白质组的T。brucei,确定T.布氏杆菌PAT,并研究这类酶作为杀锥虫化疗的潜在靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Engman其他文献

Meesmann corneal dystrophy
梅斯曼角膜营养不良
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mark Oette;Marvin J. Stone;H. Scholl;Peter Charbel Issa;M. Fleckenstein;Steffen Schmitz;Frank G. Holz;O. Strauss;Jörg;Michael Fromm;Tommie V. McCarthy;Meinhard Schiller;Stephan Grabbe;C. Sunderkötter;Gidon Almogy;Avraham I. Rivkind;Hideaki Kato;John W. Finley;Johannes Uhl;Jürgen Kopitz;Michael Cantz;Philip F. Giampietro;Inga Harting;Nicole I. Wolf;Jürgen Grabbe;Robert J. Beynon;Rosaline C. M. Quinlivan;Caroline A. Sewry;Naoto Kuroda;Cengiz Korkmaz;Anthony J. Bleyer;Thomas C. Hart;Michele Bisceglia;Carlos Galliani;Stefan Pfister;Olaf Witt;Alexander K. C. Leung;Jan Hellemans;Geert Mortier;M. Schmitt;Markus Pfister;Hans;Markus J. Riemenschneider;Guido Reifenberger;Julian F. B. Mercer;Sharon La Fontaine;Ingrid Moll;Bruce C. Kone;Stephan vom Dahl;P. Schwarz;Jiang Li;Volkmar Gieselmann;David Genevieve;Martine Le Merrer;John;Victor E. A. Gerdes;K. Beyer;Elardus Erasmus;Lodewyk J. Mienie;Jan Bubeník;Jana Šímová;Thorsten Buch;Ansgar Schulz;Irmgard Förster;Shirley Hodgson;Holger Sudhoff;Peter J. Goadsby;Karin Jurkat;Frank Lehmann;John Logan;Bernadette McGuinness;Maria Isabel Melaragno;Marcial Francis Galera;Hardally R. Hegde;Hannu Jalanko;Maria Judit Molnar;Danae Liolitsa;Charungthai Dejthevaporn;Michael G. Hanna;Josef Finsterer;Yuichi Goto;Lucia K. Ma;Patrick T. S. Ma;Toshio Nishikimi;Siobhan D. Ma;Andrew Rozelle;E. Chakravarty;Stefan R. Bornstein;Sven Schinner;Marinus Duran;William Lane M. Robson;Christine Liang;Julie V. Schaffer;Claudiu Plesa;Franck E. Nicolini;Eric Sibley;Vinzenz Oji;Heiko Traupe;Damian Miles Bailey;Heimo Mairbäurl;Peter Bärtsch;Alexander K. C. Leung;Justine H. S. Fong;M. Beck;Silke Hofmann;Leena Bruckner;Dieter Metze;Riikka H. Hämäläinen;Anna;Marita Lipsanen;Constantine A. Stratakis;Francesca Marini;Alberto Falchetti;Maria Luisa Brandi;Christian Bender Koch;Constantine A. Stratakis;Michael Briggs;Wim Wuyts;Filip Vanhoenacker;Wim Hul;Hayrettin Tumani;Kurt Von Figura;Thomas Dierks;Bernhard Schmidt;Luca Busetto;Giuliano Enzi;Thomas Klockgether;Ioannis Stefanidis;Georgios M. Hadjigeorgiou;Klaus Zerres;Sabine Rudnik‐Schöneborn;Hans;Anne;Eric P. Hoffman;Rabah Ben Yaou;Gisèle Bonne;Dominique Récan;Peter Hackman;Bjarne Udd;Wolfgang Dietmaier;Arndt Hartmann;Dominique Prié;Caroline Silve;Bernard Grandchamp;Gérard Friedlander;Andrew G. Engel;W. Kempf;R. Dummer;Günter Burg;Daniela Cilloni;Giuseppe Saglio;Ulrich S. Schuler;Ulrike Bacher;Claudia Haferlach;Susanne Schnittger;Torsten Haferlach;Reginald S. Sauve;Deepak Kamat;Stephen N. Makoni;Richard L. Sabina;Benjamin D. Tyrrell;Justin A. Ezekowitz;Wolfgang Schillinger;G. Hasenfuss;Kevin M. Bonney;David M. Engman;Thomas Klopstock;Friedrich Asmus;Thomas Gasser;Dina J. Zand;Elaine H. Zackai;Frank Schaeffel;Anders Oldfors;Niklas Darin;Tommy Martinsson;Ursula Knirsch;Gisela Stoltenburg;Olayinka Raheem;Tiina Suominen
  • 通讯作者:
    Tiina Suominen
Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology
在恰加斯病纳米治疗期间,苄硝唑递送的功效取决于纳米载体的形态
  • DOI:
    10.1016/j.biomaterials.2025.123358
  • 发表时间:
    2025-11-01
  • 期刊:
  • 影响因子:
    12.900
  • 作者:
    Debora B. Scariot;Austeja Staneviciute;Rayanne R.B. Machado;Simseok A. Yuk;Yu-Gang Liu;Swagat Sharma;Sultan Almunif;El Hadji Arona Mbaye;Celso Vataru Nakamura;David M. Engman;Evan A. Scott
  • 通讯作者:
    Evan A. Scott

David M. Engman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Engman', 18)}}的其他基金

Global Characterization of Protein Palmitoylation in Trypanosomes
锥虫中蛋白质棕榈酰化的整体表征
  • 批准号:
    8685282
  • 财政年份:
    2013
  • 资助金额:
    $ 36.54万
  • 项目类别:
Global Characterization of Protein Palmitoylation in Trypanosomes
锥虫中蛋白质棕榈酰化的整体表征
  • 批准号:
    8504116
  • 财政年份:
    2013
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7339181
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7860722
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7150838
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7424971
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7624645
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Experimental Autoimmune Myocarditis
实验性自身免疫性心肌炎的发病机制
  • 批准号:
    7271228
  • 财政年份:
    2006
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Chagas Heart Disease
恰加斯心脏病的发病机制
  • 批准号:
    6999368
  • 财政年份:
    2004
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathogenesis of Chagas Heart Disease
恰加斯心脏病的发病机制
  • 批准号:
    7184326
  • 财政年份:
    2004
  • 资助金额:
    $ 36.54万
  • 项目类别:

相似海外基金

Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
  • 批准号:
    BB/Y003756/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
  • 批准号:
    MR/Y503435/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
  • 批准号:
    10561406
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
  • 批准号:
    22KJ1113
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
  • 批准号:
    BB/X001504/1
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
  • 批准号:
    10584620
  • 财政年份:
    2022
  • 资助金额:
    $ 36.54万
  • 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
  • 批准号:
    576016-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
  • 批准号:
    10657417
  • 财政年份:
    2022
  • 资助金额:
    $ 36.54万
  • 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
  • 批准号:
    10389517
  • 财政年份:
    2022
  • 资助金额:
    $ 36.54万
  • 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
  • 批准号:
    RGPIN-2019-07122
  • 财政年份:
    2022
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了